相关实验视频

Updated: May 2, 2026

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Murine Surgical Model of Topical Elastase Induced Descending Thoracic Aortic Aneurysm

Published on: August 24, 2019

基于抗炎反应的风险评估急性甲型大动脉剖析:全国多中心队列研究

Hong Liu¹, Bing-Qi Sun², Zhi-Wei Tang¹

¹Department of Cardiovascular Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, PR China.

International journal of cardiology. Heart & vasculature

|February 5, 2024

概括

一个新的风险模型准确地预测了急性甲型大动脉剖析 (TAAD) 患者的手术死亡率. 抗炎药物乌利纳沙丁并没有降低死亡率,但在高风险患者中缩短了通风.

科学领域:

心血管外科心血管外科
胸部外科手术胸部外科手术
医疗信息学医疗信息学

背景情况:

早期识别高风险患者对于急性A型大动脉解剖 (TAAD) 至关重要.
根据风险分层,研究对抗炎药物疗法的差异反应是很重要的.

研究的目的:

开发和验证TAAD患者手术后死亡率的预测模型.
评估抗炎药物治疗 (ulinastatin) 对不同风险层的手术死亡率和结果的影响.

主要方法:

在13个中心的3110名TAAD患者的数据上使用极端梯度增强开发了一个风险模型.
该模型结合了十个关键特征:血小板-白细胞比率,D-二次体,aPTT,尿素,葡萄糖,乳酸,基过剩,血红蛋白,白蛋白和CK-MB.
亚组分析检查了乌利纳斯塔丁对低风险患者和中高风险患者的死亡率和通风持续时间的影响.

主要成果:

风险模型显示出高预测准确度 (AUC在导出时为0.943,在验证时为0.884).
乌利纳的使用并没有显著降低风险组间的手术死亡率.
乌利纳斯与中高风险患者的机械通风持续时间缩短有关 (P=0.048).

结论:

开发的风险模型有效预测TAAD手术中的手术死亡率,整合炎症,凝血和代谢因素.
这个模型可以帮助TAAD患者个性化抗炎药物治疗策略.
乌利纳斯可能有助于降低高风险TAAD患者的通风时间.

关键词:

极端的梯度增强了极端的梯度.机器学习机器学习操作性死亡率操作性死亡率一种类型的甲动脉剖析.

更多相关视频

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Novel and Innovative Hybrid Technique for Type A Aortic Dissection

Published on: March 28, 2025

相关概念视频

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...